Assay failure occurs in around 1.5% of cases (manuscript in preparation) and there is a rare theoretical risk of false positives due to the presence of epithelial inclusions [23,24] or the expression of CK19 in some high-grade lymphomas [25,26]. This evidence concerns the gene KRT19 and lymphoma.